AP-161

N/A

Report date: 2024/04/24 14:56:17

Base Information

Drug NameAP-161
Drug Alias NameAP-161
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionHSP70 heat-shock proteins modulators
TargetsHSP70 heat-shock proteins
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlphageneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlphageneron Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A